Counselors in Wellington, CO Accepting Medicare

6 Counselors found. Showing 1 - 6

John Brian Garner, LPC, LAC Counselor - Addiction (Substance Use Disorder) Medicare: Not Enrolled in Medicare Practice Location: 9039 Smoke Signal Way, Wellington, CO 80549 Phone: 970-632-2362

Deborah Ann Coyote, MA, LPC, NCC Counselor - Professional Medicare: Medicare Enrolled Practice Location: 7840 1st St, Wellington, CO 80549 Phone: 970-402-3135

Rachel Kathleen Hayes, LPC, EMDR Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 3328 Wild West Ln, Wellington, CO 80549 Phone: 970-445-1830

Ms. Laura Garrett, LPC NCC CACIII Counselor - Addiction (Substance Use Disorder) Medicare: Not Enrolled in Medicare Practice Location: 3527 Cleveland Ave, Wellington, CO 80549 Phone: 970-420-4526

Waylon Cosner, LPCC Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 6557 Buttercup Dr Unit 5, Wellington, CO 80549 Phone: 720-805-4951

Natasha Trujillo, LPC Counselor Medicare: Accepting Medicare Assignments Practice Location: 7950 6th St, Wellington, CO 80549 Phone: 970-888-4070    Fax: 970-372-6412

News Archive

Pacific Biosciences completes $109M Series F financing round

Pacific Biosciences, a private company developing a disruptive technology platform for real-time detection of biological events at single molecule resolution, today announced it has completed a Series F round of financing in the amount of $109 million.

Aspirin offers help for Barrett's esophagus

Researchers at Fred Hutchinson Cancer Research Center have found that people with the most-aggressive form of Barrett's esophagus, a precancerous condition that can lead to esophageal cancer, may benefit the most from preventive therapy with aspirin, ibuprofen and other nonsteroidal anti-inflammatory drugs, or NSAIDs.

Sepracor's STEDESA NDA: FDA extends PDUFA action date

Sepracor Inc. today announced that it has received notification from the U.S. Food and Drug Administration (FDA) that the agency now anticipates completing its review of the STEDESA™ (eslicarbazepine acetate) New Drug Application (NDA) on April 30, 2010, which is a three-month extension to the original Prescription Drug User Fee Act (PDUFA) date of January 30, 2010.

DNA Medicine Institute awarded Grand Challenges Explorations grant to develop finger scanner for malaria

The DNA Medicine Institute announced today that it has received a US$100,000 Grand Challenges Explorations grant from the Bill & Melinda Gates Foundation. The grant will support an innovative global health research project conducted by Eugene Y. Chan, M.D. titled "Optomagnetic Finger Scanner for Malaria."

Read more Medical News

› Verified 6 days ago